Citation: Pd. Miller et al., CYCLICAL ETIDRONATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS -EFFICACY AND SAFETY AFTER 7 YEARS OF TREATMENT (VOL 103, PG 468, 1997), The American journal of medicine, 104(6), 1998, pp. 608-608
Authors:
MILLER PD
ADACHI JD
BROWN JP
KHAIRI RA
LANG R
LICATA AA
MCCLUNG MR
RYAN WG
SINGER FR
SIRIS ES
TENENHOUSE A
WALLACH S
BEKKER PJ
AXELROD DW
Citation: Pd. Miller et al., RISEDRONATE VS ETIDRONATE PAGETS STUDY - DURABLE REMISSION WITH ONLY 2 MONTHS OF 30 MG RISEDRONATE, Journal of bone and mineral research, 12, 1997, pp. 670-670
Authors:
BEKKER PJ
MILLER PD
ADACHI JD
BROWN JP
KHAIRI RA
LANG R
LICATA AA
MCCLUNE MR
RYAN WG
SINGER FR
SIRIS ES
TENENHOUSE A
WALLACH S
AXELROD DW
Citation: Pj. Bekker et al., RISEDRONATE TREATMENT IMPROVES PAIN STATUS IN PATIENTS WITH PAGETS-DISEASE OF BONE, Journal of bone and mineral research, 12, 1997, pp. 673-673
Authors:
NEUMANN DR
ESSELSTYN CB
MACINTYRE WJ
CHEN EQ
GO RT
LICATA AA
Citation: Dr. Neumann et al., REGIONAL BODY FDG-PET IN POSTOPERATIVE RECURRENT HYPERPARATHYROIDISM, Journal of computer assisted tomography, 21(1), 1997, pp. 25-28
Authors:
BONE HG
DOWNS RW
TUCCI JR
HARRIS ST
WEINSTEIN RS
LICATA AA
MCCLUNG MR
KIMMEL DB
GERTZ BJ
HALE E
POLVINO WJ
Citation: Hg. Bone et al., DOSE-RESPONSE RELATIONSHIPS FOR ALENDRONATE TREATMENT IN OSTEOPOROTICELDERLY WOMEN, The Journal of clinical endocrinology and metabolism, 82(1), 1997, pp. 265-274
Authors:
MILLER PD
WATTS NB
LICATA AA
HARRIS ST
GENANT HK
WASNICH RD
ROSS PD
JACKSON RD
HOSEYNI MS
SCHOENFELD SL
VALENT DJ
CHESNUT CH
Citation: Pd. Miller et al., CYCLICAL ETIDRONATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS -EFFICACY AND SAFETY AFTER 7 YEARS OF TREATMENT, The American journal of medicine, 103(6), 1997, pp. 468-476
Authors:
NEUMANN DR
ESSELSTYN CB
MACINTYRE WJ
GO RT
OBUCHOWSKI NA
CHEN EQ
LICATA AA
Citation: Dr. Neumann et al., COMPARISON OF FDG-PET AND SESTAMIBI-SPECT IN PRIMARY HYPERPARATHYROIDISM, The Journal of nuclear medicine, 37(11), 1996, pp. 1809-1815
Citation: Kj. Harjai et Aa. Licata, AMIODARONE-INDUCED HYPERTHYROIDISM - A CASE SERIES AND BRIEF REVIEW OF LITERATURE, PACE, 19(11), 1996, pp. 1548-1554
Citation: Aa. Licata, TREATMENT OF OSTEOPOROSIS IN A PATIENT WITH HOMOCYSTINEMIA(URIA) USING ETIDRONATE DISODIUM AND PYRIDOXINE, Journal of bone and mineral research, 10, 1995, pp. 509-509
Authors:
NEUMANN DR
ESSELSTYN CB
MACINTYRE WJ
GO RT
OBUCHOWSKI N
CHEN EQ
KOHSE LM
LICATA AA
Citation: Dr. Neumann et al., COMPARISON OF FDG PET AND DOUBLE-PHASE SESTAMIBI SPECT IN THE PREOPERATIVE EVALUATION OF PRIMARY HYPERPARATHYROIDISM, The Journal of nuclear medicine, 35(5), 1994, pp. 160000068-160000068
Authors:
NEUMANN DR
ESSELSTYN CB
MACINTYRE WJ
CHEN EQ
GO RT
KOHSE LM
LICATA AA
Citation: Dr. Neumann et al., PRIMARY HYPERPARATHYROIDISM - PREOPERATIVE PARATHYROID IMAGING WITH REGIONAL BODY FDG PET, Radiology, 192(2), 1994, pp. 509-512
Authors:
NEUMANN DR
ESSELSTYN CB
SICILIANO D
MACINTYRE WJ
KOHSE LM
LICATA AA
Citation: Dr. Neumann et al., IMAGING CASE-STUDY OF THE MONTH - PREOPERATIVE IMAGING OF PARATHYROIDCARCINOMA BY POSITRON EMISSION TOMOGRAPHY, The Annals of otology, rhinology & laryngology, 103(9), 1994, pp. 741-745
Citation: Aa. Licata, FROM BATHTUB RING TO OSTEOPOROSIS - A CLINICAL REVIEW OF THE BISPHOSPHONATES, Cleveland Clinic journal of medicine, 60(4), 1993, pp. 284-290
Authors:
LICATA AA
CHESNUT CH
GENANT HK
HARRIS ST
JACKSON RD
MILLER PD
ROSS PD
WASNICH RD
WATTS NB
Citation: Aa. Licata et al., EFFECTS OF 2 YEARS FOLLOW-UP CYCLICAL ETIDRONATE TREATMENT IN POSTMENOPAUSAL OSTEOPOROTIC WOMEN, Journal of bone and mineral research, 8, 1993, pp. 190000141-190000141
Citation: Am. Lee et al., CLINICAL-EXPERIENCE WITH CYCLICAL ETIDRONATE IN PATIENTS WITH OSTEOPOROSIS, Journal of bone and mineral research, 8, 1993, pp. 190000247-190000247
Citation: Am. Gliga et Aa. Licata, CLINICAL SURVEY OF THE ANALGESIC EFFECTS OF INJECTABLE CALCITONIN, Journal of bone and mineral research, 8, 1993, pp. 190000334-190000334
Authors:
HARRIS ST
WATTS NB
JACKSON RD
GENANT HK
WASNICH RD
ROSS P
MILLER PD
LICATA AA
CHESNUT CH
Citation: St. Harris et al., 4-YEAR STUDY OF INTERMITTENT CYCLIC ETIDRONATE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS - 3 YEARS OF BLINDED THERAPY FOLLOWED BY ONE-YEAR OF OPEN THERAPY, The American journal of medicine, 95(6), 1993, pp. 557-567